(Reuters) – Merck & Co said on Monday the U.S. Food and Drug Administration has placed clinical holds on trials testing the company’s HIV drug islatravir.
(Reporting by Dania Nadeem in Bengaluru)
U.S. FDA puts Merck’s HIV drug trials on hold
Dec 13, 2021 | 5:30 PM
